PAREXEL/Univ. of Singapore deliver Academic Program

November 2011
Worldwide Biotech;Nov2011, Vol. 23 Issue 11, p2
Trade Publication
The article reports on the agreement of Parexel Academy with the National University of Singapore (NUS), through its NUS Academy of GxP Excellence (NUSAGE), to offer an academic program in Singapore to help meet the growing demand for talent in clinical research. Parexel International Vice President Doctor Albert Siu expects the alliance to deliver a world class program focused on global best practices. The initiative is anticipated to equip clinical development professionals with vital skills.


Related Articles

  • NUS nurtures Singapore's higher education. John, Biyanka Merlyn // Education Insider;Mar2013, Vol. 2 Issue 3, p56 

    The article focuses on the National University of Singapore (NUS), Singapore's flagship university that offers a global approach to education and research. NUS is situated at Kent Ridge, Singapore and was established on January 1, 1962. Some of its programmes include Student Exchange Programme,...

  • A Light at the End of the R&D Pipeline. Shapiro, Marissa // Applied Clinical Trials;Oct2008, Vol. 17 Issue 10, p18 

    The article reports on the data published in the "U.S. Drug Approval Trends and Yearbook 2008/2009" by Parexel International Ltd. It indicates an increase in the marketing applications for new molecular entities (NMEs) which offers the best measure for true drug development outputs. It also...

  • New measures introduced to monitor gene therapy trials. Hollon, Tom // Nature Medicine;May2000, Vol. 6 Issue 5, p486 

    Reports that James M. Wilson, director of the Institute for Human Gene Therapy, has reorganized his institute to ensure compliance with U.S. Food and Drug Administration requirements. Hiring of a clinical research organization, Parexel International, to monitor procedures and documentation of...

  • Industry Briefs.  // CenterWatch Weekly;11/23/2015, Vol. 19 Issue 46, p2 

    The article offers pharmaceutical news briefs which includes joint program between the U.S. pharmaceutical company Parexel International and Kyoto Pharmaceutical University (KPU), Japan for clinical research; accreditation received by St. George University, Grenada; and denial of medicine...

  • PAREXEL EXPANDS RELATIONSHIP WITH SYNCHRON IN INDIA.  // Worldwide Biotech;May2008, Vol. 20 Issue 5, p3 

    The article reports on the expansion of the minority interest of Parexel International Corporation in the clinical pharmacology business of Synchron Research in Ahmedabad, India. The sale of a bioanalytical laboratory in Poitiers, France to a subsidiary of Synchron, Synexel Research...

  • Women on the Board in Singapore.  // BizEd;Jan/Feb2012, Vol. 11 Issue 1, p10 

    The article focuses on the 2012 report collaborated by the Centre for Governance, Institutions, and Organizations (CGIO) of the National University of Singapore and BoardAgender which shows 6.9% of board members of companies listed in Singapore Exchange (SGX) are represented by women.

  • Tree frogs inspire graphene transfer process.  // TCE: The Chemical Engineer;Feb2014, Issue 872, p21 

    The article presents the development of a new method by the National University of Singapore (NUS) to grow graphene on solid substrates and deal problems with transferring it, inspired by how tree frogs stick to submerged leaves.

  • Current Status of Subfamily Ichneumoninae (Hymenoptera: Ichneumonidae) from Malaysia and Singapore. Norhafiza, A. F.; Idris, A. B. // AIP Conference Proceedings;Dec2013, Vol. 1571 Issue 1, p308 

    In this paper, 25 genera and 38 species under 10 tribes (Alomyini, Compsophorini, Goedartiini, Heresiarchini, Ichneumonini, Ischnojoppini, Joppocryptini, Listrodromini, Oedicephalini and Platylabini) of the subfamily Ichneumoninae housed in the Centre for Insect Systematics, UKM and Raffles...

  • Clinical Research.  // Pharmaceutical Executive;Dec2007 Supplement, p16 

    The article offers a corporate profile for several clinical research companies in the U.S. Covance Inc. provides drug development services to pharmaceutical and biotechnology companies of all sizes. PAREXEL International Corp. helps advance healthcare discoveries by providing expertise...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics